Training/Dissemination - Resource for Molecular Imaging Agents in Precision Medicine

培训/传播 - 精准医学分子成像剂资源

基本信息

  • 批准号:
    10226214
  • 负责人:
  • 金额:
    $ 9.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-15 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

TRAINING and DISSEMINATION SUMMARY Training and dissemination is an imperative component of the BTRC. The purpose of the Training and Dissemination Core will be to systematize and optimize what we can do to educate interested members of the molecular imaging community. Training will be conducted by members of the BTRC, particularly the Executive Committee, who have extensive experience in conducting a variety of training programs ranging from online modules to the performance of live, hands-on experiments. Due to the many functions of the BTRC there are many opportunities to provide meaningful experiences to collaborators and service recipients. We currently train graduate students, postdocs, rotating residents, fellows, and visiting scholars. In the BTRC we will expand training into the wider community and add the dimension of training participants in Collaborative and Service Projects (CPs and SPs). We are particularly interested in training physicians, as they can provide unique insight into need and practicality of translating agents of the BTRC and seek to promote their increased engagement. We will also provide an immersion experience in the development of molecular imaging agents as we have in the past with pre-clinical imaging. Training will occur through five mechanisms: (1) A bi-annual, two-and-one-half day immersion course in Precision Molecular Imaging Agents: Concept to Clinic; (2) online modules for image analysis, particularly quantitative analysis of human images; (3) lectures, in association with continuing medical education (CME) and other ongoing courses. For example, a bi-annual, two-and-one-half day chemical exchange saturation transfer (CEST) imaging workshop, featuring the latest research from Drs. van Zijl, McMahon and Bulte. Based on interest, we may also add a more basic training course utilizing our textbook: Chemical Exchange Saturation Transfer Imaging: Advances and Applications, and on the CEST simulation and data processing software packages found on the F.M. Kirby Research Center's website. Other mechanisms are (4) through mini- sabbaticals to interested individuals within the molecular imaging community; and (5) formal site visits and reverse site visits – in person or via Skype – with participants in the CPs and SPs. Investigators within the BTRC are dedicated to sharing and disseminating developed technology and resources. As with training, this is currently on a case-by-case basis. However, dissemination is essential to garner commercial interest, as is reflected in our CPs and SPs. Dissemination will primarily occur as: (1) publications in peer-reviewed journals and other media; (2) distribution of materials, protocols, INDs; (3) licensing through Johns Hopkins Technology Ventures; (4) on-site training (conflating training and dissemination); (5) an educational website; and (6) providing raw image data online.
培训和传播 摘要 培训和传播是BTRC的一个重要组成部分。培训的目的和 传播的核心将是系统化和优化我们可以做的事情,以教育感兴趣的成员 分子成像社区。培训将由BTRC成员,特别是执行人员进行 委员会,他们在开展各种培训计划方面有丰富的经验,从在线 模块到现场实操实验的表现。由于BTRC的许多职能,有 许多机会为合作者和服务接受者提供有意义的体验。我们目前正在培训 研究生、博士后、轮值住院医师、研究员和访问学者。在BTRC,我们将扩大 培训进入更广泛的社区,并增加协作和服务培训参与者的维度 项目(CPS和SPS)。我们对培训医生特别感兴趣,因为他们可以提供独特的见解 了解BTRC翻译人员的需要和实际情况,并努力促进他们更多地参与。 我们还将提供分子显像剂开发的沉浸体验,就像我们在 过去的临床前成像。 培训将通过五个机制进行:(1)一年两次、为期两天半的浸入式培训课程 精密分子成像剂:临床概念;(2)图像分析的在线模块,特别是 人体图像的量化分析;(3)与继续医学教育(CME)和 其他正在进行的课程。例如,一年两次、两天半的化学交换饱和转移 (CEST)成像研讨会,以van Zijl、McMahon和Bulte博士的最新研究为特色。基于 感兴趣,我们还可以增加一个更基本的培训课程,利用我们的教科书:化学交换饱和 传递成像:进展和应用,以及CEST模拟和数据处理软件 在F.M.柯比研究中心的网站上找到的包裹。其他机制是(4)通过微型 对分子成像社区内感兴趣的个人的休假;以及(5)正式的现场访问和 与CPS和SPS的参与者面对面或通过Skype进行现场访问。 BTRC内的调查人员致力于分享和传播已开发的技术和资源。 与培训一样,这目前是在个案基础上进行的。然而,传播是获得 商业利益,这反映在我们的CPS和SPS中。传播将主要通过以下方式进行:(1)出版物 同行评议的期刊和其他媒体;(2)分发材料、方案、索引;(3)通过约翰斯发放许可证 霍普金斯技术风险投资公司;(4)现场培训(培训和传播相结合);(5)教育 网站;(6)在线提供原始图像数据。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARTIN G POMPER其他文献

MARTIN G POMPER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARTIN G POMPER', 18)}}的其他基金

Translational imaging biomarkers of the tumor microenvironment in early prostate cancer
早期前列腺癌肿瘤微环境的转化成像生物标志物
  • 批准号:
    10698133
  • 财政年份:
    2022
  • 资助金额:
    $ 9.33万
  • 项目类别:
Translational imaging biomarkers of the tumor microenvironment in early prostate cancer
早期前列腺癌肿瘤微环境的转化成像生物标志物
  • 批准号:
    10518916
  • 财政年份:
    2022
  • 资助金额:
    $ 9.33万
  • 项目类别:
Resource for Molecular Imaging Agents in Precision Medicine
精准医学分子成像剂资源
  • 批准号:
    10226206
  • 财政年份:
    2017
  • 资助金额:
    $ 9.33万
  • 项目类别:
Administration - Resource for Molecular Imaging Agents in Precision Medicine
管理 - 精准医学中分子成像剂的资源
  • 批准号:
    10226207
  • 财政年份:
    2017
  • 资助金额:
    $ 9.33万
  • 项目类别:
Imaging Agents for Inflammatory Components of Malignancy
恶性肿瘤炎症成分的显像剂
  • 批准号:
    10226210
  • 财政年份:
    2017
  • 资助金额:
    $ 9.33万
  • 项目类别:
Small Molecule PSMA-Targeted Alpha Therapy
小分子 PSMA 靶向阿尔法疗法
  • 批准号:
    10594010
  • 财政年份:
    2014
  • 资助金额:
    $ 9.33万
  • 项目类别:
Small Molecule PSMA-Targeted Alpha Therapy
小分子 PSMA 靶向阿尔法疗法
  • 批准号:
    10411890
  • 财政年份:
    2014
  • 资助金额:
    $ 9.33万
  • 项目类别:
Small Molecule PSMA-Targeted Alpha Therapy
小分子 PSMA 靶向阿尔法疗法
  • 批准号:
    9886363
  • 财政年份:
    2014
  • 资助金额:
    $ 9.33万
  • 项目类别:
Small Molecule PSMA-Targeted Alpha Therapy
小分子 PSMA 靶向阿尔法疗法
  • 批准号:
    8671057
  • 财政年份:
    2014
  • 资助金额:
    $ 9.33万
  • 项目类别:
Small Molecule PSMA-Targeted Alpha Therapy
小分子 PSMA 靶向阿尔法疗法
  • 批准号:
    10092113
  • 财政年份:
    2014
  • 资助金额:
    $ 9.33万
  • 项目类别:

相似海外基金

CAS-SC: Tuning Hydrocarbon Products from Temperature-Gradient Thermolysis of Polyolefins and the Subsequent Upcycling to Functional Chemicals
CAS-SC:调整聚烯烃温度梯度热解的碳氢化合物产品以及随后升级为功能化学品
  • 批准号:
    2411680
  • 财政年份:
    2024
  • 资助金额:
    $ 9.33万
  • 项目类别:
    Standard Grant
Building Synthetic Biofilm Consortia for Polyfluorinated Chemicals Biodegradation
建立多氟化学品生物降解合成生物膜联盟
  • 批准号:
    2343831
  • 财政年份:
    2024
  • 资助金额:
    $ 9.33万
  • 项目类别:
    Standard Grant
Removal of Perfluorinated Chemicals Using New Fluorinated Polymer Sorbents
使用新型氟化聚合物吸附剂去除全氟化化学品
  • 批准号:
    LP220100036
  • 财政年份:
    2024
  • 资助金额:
    $ 9.33万
  • 项目类别:
    Linkage Projects
The University of Liverpool and Pegasus Chemicals Limited KTP 22_23 R5
利物浦大学和飞马化学有限公司 KTP 22_23 R5
  • 批准号:
    10063790
  • 财政年份:
    2024
  • 资助金额:
    $ 9.33万
  • 项目类别:
    Knowledge Transfer Partnership
PINK - Provision of Integrated Computational Approaches for Addressing New Markets Goals for the Introduction of Safe-and-Sustainable-by-Design Chemicals and Materials
PINK - 提供综合计算方法来解决引入安全和可持续设计化学品和材料的新市场目标
  • 批准号:
    10097944
  • 财政年份:
    2024
  • 资助金额:
    $ 9.33万
  • 项目类别:
    EU-Funded
Safe and Sustainable by Design framework for the next generation of Chemicals and Materials
下一代化学品和材料的安全和可持续设计框架
  • 批准号:
    10110559
  • 财政年份:
    2024
  • 资助金额:
    $ 9.33万
  • 项目类别:
    EU-Funded
Optimising Nature's pharmacies: plant chemicals and pollinator health at the landscape scale
优化大自然的药房:景观尺度上的植物化学物质和传粉媒介健康
  • 批准号:
    NE/Y000285/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.33万
  • 项目类别:
    Research Grant
Converting lignin condensed structures into high-value polyaromatic hydrocarbon chemicals by controlled pyrolysis
通过受控热解将木质素缩合结构转化为高价值的多芳烃化学品
  • 批准号:
    24K17940
  • 财政年份:
    2024
  • 资助金额:
    $ 9.33万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
INSIGHT: Integrated Models for the Development and Assessment of High Impact Chemicals and Materials
洞察力:高影响化学品和材料开发和评估的综合模型
  • 批准号:
    10097888
  • 财政年份:
    2024
  • 资助金额:
    $ 9.33万
  • 项目类别:
    EU-Funded
ELectrochemical OXidation of cYclic and biogenic substrates for high efficiency production of organic CHEMicals (ELOXYCHEM)
用于高效生产有机化学品的循环和生物底物的电化学氧化 (ELOXYCHEM)
  • 批准号:
    10110221
  • 财政年份:
    2024
  • 资助金额:
    $ 9.33万
  • 项目类别:
    EU-Funded
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了